Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.44 |
| ▸ | CA2 | P00918 | 9/20 | 0.44 |
| ▸ | CA9 | Q16790 | 8/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.44 |
| ▸ | CA3 | P07451 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA6 | P23280 | 2/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7157641 | 1.00 | CA1 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL11669727 | 1.00 | CA1 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL7918395 | 1.00 | CA1 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL7927231 | 1.00 | CA1 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL7918378 | 1.00 | CA1 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL7923990 | 1.00 | CA1 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL7918384 | 1.00 | CA1 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL9498994 | 0.97 | CA1 (0.42) | CA1CA2CA9CA12CA7 | |
| SCHEMBL13286589 | 0.90 | THRB (0.40) | CA1CA2CA9CA12CA7 | |
| SCHEMBL15256773 | 0.89 | CA1 (0.38) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0860411-B1 | Improved catalytic composition for the conversion of ethylene to alpha olefins | INST FRANCAIS DU PETROLE (FR) | 2003-10-29 | — | — | EP | claimed |
| US-6221986-B1 | CATALYTIC OLIGOMERIZATION | INSTITUT FRANCAIS DU PETROLE (FR) | 2001-04-24 | — | — | US | claimed |
| US-6103654-A | Catalytic composition and a process for converting ethylene to light alpha olefins | INSTITUT FRANCAIS DU PETROLE (FR) | 2000-08-15 | — | — | US | claimed |
| EP-0578541-B1 | Process for the preparation of light alpha-olefines by oligomerisation of ethylene | INST FRANCAIS DU PETROLE (FR) | 1997-12-03 | — | — | EP | claimed |
| US-5496783-A | CATALYSIS WITH MIXTURE OF ZIRCONIUM COMPOUND, ACETAL OR KETAL, AND ORGANOALUMINUM BROMIDE OR CHLORIDE | INSTITUT FRANCAIS DU PETROLE (FR) | 1996-03-05 | — | — | US | claimed |
| US-5345023-A | Zirconium coordination catalysts with acetals and ketals | INSTITUT FRANCAIS DU PETROLE (FR) | 1994-09-06 | — | — | US | claimed |
| EP-1099983-B1 | Chemically amplified positive resist composition and patterning method | SHINETSU CHEMICAL CO (JP) | 2014-08-06 | — | — | EP | disclosed |
| EP-1288186-B1 | Preparation process of vinyl ether compounds | DAICEL CHEM (JP) | 2007-09-19 | — | — | EP | disclosed |
| US-7271297-B2 | Process for producing vinyl ether compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-18 | — | — | US | disclosed |
| EP-1826196-A2 | Vinyl ether compounds | Daicel Chemical Industries, Ltd. (JP) | 2007-08-29 | — | — | EP | disclosed |
| US-20060205957-A1 | Process for producing vinyl ether compounds | ISHII YASUTAKA | 2006-09-14 | — | — | US | disclosed |
| US-7074970-B2 | Process for producing vinyl ether compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-0893442-B1 | LYMPH-ABSORBABLE IMIDAZOLE DERIVATIVES | SHIONOGI & CO (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-6221986-B1 | CATALYTIC OLIGOMERIZATION | INSTITUT FRANCAIS DU PETROLE (FR) | 2001-04-24 | — | — | US | disclosed |
| US-6103654-A | Catalytic composition and a process for converting ethylene to light alpha olefins | INSTITUT FRANCAIS DU PETROLE (FR) | 2000-08-15 | — | — | US | disclosed |
| US-6054591-A | LYMPHOTROPIC ANTI-AIDS AGENT | SHIONOGI & CO., LTD. (JP) | 2000-04-25 | — | — | US | disclosed |
| EP-0893442-A1 | LYMPH-ABSORBABLE IMIDAZOLE DERIVATIVES | SHIONOGI & CO., LTD. (JP) | 1999-01-27 | — | — | EP | disclosed |
| US-4038478-A | ANTIBACTERIAL AGENTS | THE UPJOHN COMPANY (US) | 1977-07-26 | — | — | US | disclosed |
| US-3996205-A | BACTERICIDES | THE UPJOHN COMPANY (US) | 1976-12-07 | — | — | US | disclosed |
| US-3984393-A | BACTERICIDES | THE UPJOHN COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205957-A1 | Process for producing vinyl ether compounds | ETV6, CYP3A4, SUV39H2 | CA1 2983/4885CA2 3463/4885CA9 1749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.